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An Experimental Investigation of
Health Insurance Policy and Behavior
J. Dustin Tracy*, Hillard Kaplan, Kevin A. James, and Stephen J. Rassenti
Economic Science Institute, Chapman University
September 26, 2020
Abstract
We introduce a new experimental approach to measuring the effects of health insurance policy alternatives on behavior and health outcomes over the life course. Cash-motivated subjects
are placed in a virtual environment where they earn income and allocate it across multi-period
lives. We compare behavior across age, income and insurance plans—one priced according to
an individual’s expected cost and the other uniformly priced through employer-implemented
cost sharing. We find that 1) subjects in the employer-implemented plan purchased insurance
at higher rates; 2) the employer-based plan reduced differences due to income and age; 3) subjects in the actuarial plan engaged in more health-promoting behaviors, but still below optimal
levels, and did save at the level required, so did realize the full benefits of the plan. Subjects
had more difficulty optimizing choices in the Actuarial treatment, because it required more long
term planning and evaluating benefits that compounded over time. Contrary, to model predictions, the actuarial priced insurance plan did not increase utility relative to the employer-based
plan.
Keywords: Health insurance, Moral hazard, Inter-generational, Subsidies, Actuarially fair,
Employer-based
JEL-Codes: I11, I12, I13, I14
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Introduction

US health care costs consume 17.5% of GDP (CDC, 2018), or nearly 10,000 per person, close to
twice that of other developed nations (OECD, 2017, CMS, 2019a). At the household level, these
costs can result in bankruptcies and other financial hardships (CFPB, 2014). Yet, even with this vast
spending, there are still unmet medical needs. 64% of Americans say that have avoided or delayed
medical care in the last year due to expected costs (20—20 Research, 2018). This combination of
high costs and unmet need have led to on-going debate about healthcare and insurance reform.
* Corresponding

author: tracy@chapman.edu
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Much of the debate regarding health insurance policy concerns individual freedom and responsibility versus universal coverage and reducing health disparities (Moffit et al., 2019). Proponents
of universal coverage argue that it improves the average health of the population, decreases disparities in health outcomes within the population, and generates efficiencies by eliminating the
transactions costs associated with private insurance billing systems. Proponents of systems emphasizing individual responsibility argue two points: first, that such plans allow people to exert their
own priorities in health decisions regarding how much and what kind of coverage to purchase; and
second, if insurance premiums and co-pays depend on health behavior, such as smoking, exercise
and diet, people will have incentives to improve their health, reducing the total costs of health care.
There is a growing body of research designed to measure the effects of policy alternatives with
respect to individual responsibility and social cost sharing. One approach is to take advantage of
cross-national data to measure the impacts of health insurance alternatives on patient behavior,
population health and health disparities (NRC, 2010, IOM, 2013). That research shows that health
outcomes in the U.S. have been decreasing in recent decades relative to other developed countries,
who all practice universal cost sharing. However, given that many other nation-level variables covary with insurance policy (NRC, 2010, IOM, 2013), it has been difficult to determine whether
differences in health insurance policies are responsible for the trend and to pinpoint the causes of
the decreasing relative status of the US.
Another approach is to take advantage of ‘natural experiments’ associated with policy changes,
such the Oregon Medicaid Expansion, the SSDI Accelerated Benefits Demonstration Project, RomneyCare and ObamaCare (Weathers and Stegman, 2012, Courtemanche and Zapata, 2014, Finkelstein et al., 2015, Lipton and Decker, 2015, Courtemanche et al., 2018, Ghosh et al., 2019). Those
studies confirm that health care usage increases in response to more generous insurance benefits.
They have been less conclusive, however, about the health benefits from the additional spending
and services. There is evidence that self-reported health increases with increased health insurance coverage in Oregon (Baicker and Finkelstein, 2011) and with ‘RomneyCare’ in Massachusetts
(Courtemanche and Zapata, 2014), but effects on objective measures of health were not detected
(see also Weathers and Stegman (2012)) with respect to mortality following the Affordable Care
Act. The assessment of long term impacts is limited by the fact that all are relatively recent reforms,
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in comparison to the decades over which chronic diseases develop.
There is also a rich literature of field experiments offering financial incentives for health promoting
behavior. Giné et al. (2010) show that financial incentives can promote smoking cessation. Volpp
et al. (2008) show that incentives can induce subjects to lose weight in the short term, but in the
long-term, post-incentive period the weight is regained. Incentives can also be used to increase
gym attendance and exercise. Again, it is not clear that healthy behaviors are sustained in the
post-incentive period. See Mitchell et al. (2013) and Barte and Wendel-Vos (2017) for systematic
reviews. In general, this research shows financial incentives influence people to adapt healthier
behaviors. However, given their short time frames, such experiments are limited in their ability to
measure the effects of interventions on health outcomes and cost.
These bodies of research illustrate the methodological challenges in assessing the effects of policy
alternatives with respect to population health and total health care costs. The vast majority of
healthcare costs and disease burdens are associated with important risk factors directly or indirectly behavioral, such as an obesogenic diet, lack of physical activity, smoking and drug use. In
addition, the effects of behavior accumulate over many decades, suggesting that full policy impacts
may accumulate slowly over time. Another challenge is that people can prepare for, and prevent,
disease events along several different fronts. Examples are saving money, purchasing health insurance, changing habitual behavior, and engaging in preventative surveillance and treatment. Since
different policies may affect the value of investing in those fronts, assessing total impacts will require an understanding of potential substitutions and complements between policies and individual
behavior. Because of these challenges, there is very little causal evidence regarding the impacts of
healthcare policy alternatives, despite the very precise statistics on costs and morbidity and the
vigor of the policy debate.
This paper introduces a new, complementary experimental economic approach to address those
challenges in examining the effects of health insurance policy alternatives on behavior and health
outcomes over the life course. This experiment compares two types of premium systems for health
insurance, one based on individual responsibility and the other on group-level cost and risk sharing.
Our experimental design tests predictions as to how cost sharing in health insurance premiums

3

impact the following outcomes: 1) decisions about whether to purchase insurance; 2) behaviors
that prevent or increase the risk of adverse health events; 3) overall health levels; 4) longevity; 5)
savings; 6) overall welfare and 7) disparities in health and welfare due to income and age.
The paper proceeds as follows. The next section presents detailed descriptions of the the experimental environment and research design, the theoretical model motivating the experiment, and
theoretical results which show how the optimal time paths of consumption and investments in
health should vary as a function of the insurance and income treatments, from which we make predictions of subject behavior. Section three presents the empirical results and analyzes the treatment
effects on subject behavior. The discussion section presents a summary of our main findings and
discusses some weaknesses in the current design and appropriate directions for future research.
The conclusion addresses how our approach complements existing approaches.

2
2.1

Methods
Environment and Treatments

Our test environment, based on the Grossman (1972) lifecycle model of health investment, is
designed to model the multiple health-related decisions people make in their daily lives and the
different ways people can prepare for and ameliorate disease events. Subjects live multi-period
lives and have a stock of health that naturally deteriorates each period, and declines further if the
subject suffers a stochastic illness event (Khwaja, 2002), which we call a health ‘shock.’ Each period, subjects receive an income (an allocation of virtual currency) that depends positively on their
income class and their individual health (Viscusi and Evans, 1990) Subjects must then decide on
how to allocate their income to current consumption versus health-related investments and savings. Health-related investments include the purchase of health insurance, the purchase of health
recovery from deterioration and shocks, and expenditures on physical condition, which we call resilience, that lowers the size of potential future shocks. The ability to invest in resilience is designed
to capture preventative behaviors such as exercise, diet and abstention from smoking, drugs, etc.
whereas health recovery investment is meant to model services from medical providers, pharmaceuticals, etc. The probability of health ‘shocks’ increases during the second half of life to capture
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the effects of aging. Insurance pays for health recovery from shocks but does not compensate for
natural deterioration.
The first treatment is actuarially-based insurance, in which the cost of each individual subject’s
premium depends on that subject’s current expected health care costs to the insurer, which, in
turn, depends on that subject’s age, health state, and health-related behavior. The actuarial plan
embodies the concept of individual responsibility in a competitive insurance marketplace. Each
subject chooses whether or not to purchase insurance given her personal premium. To alleviate
the costs of premiums and continuing health degradation, subjects can invest in resilience, save
to buffer against health shocks, and directly invest in improving current health. The actuarial
plan smooths the lumpy costs of health shocks and provides incentives for individuals to improve
their health. However, it may generate significant inequality in health outcomes, due to variable
premium costs associated with individual conditions.
The second treatment is employer-based insurance, resembling the plans most Americans have.
Premiums are largely subsidized by the employer (funded through a reduction in wages), and
there is social cost sharing: all employees have no choice but to contribute to the employer’s costs
through universal proportionate wage reductions. The premium the employer must pay the insurer
is determined by the average expected costs of all employees who choose the plan. The proportion
of the premium paid directly by the employee is fixed, regardless of age, income, health state or
behavior. The employer treatment and its incentives differ significantly from the actuarial plan.
First, since premiums do not depend on resilience, there is less incentive to invest in prevention
(often referred to as, ‘moral hazard’). Second, people with greater risk (the ‘old’) would have
a greater incentive to purchase the insurance since their expected health costs would be greater
(often referred to as, ‘adverse selection’). However, this plan is expected to generate less inequality
in health outcomes due to social cost sharing.
Subjects were assigned to one of four experimental treatments groups in a 2x2 experimental design.
One treatment dimension was the actuarial versus employer insurance plan, and the other was high
versus low income. In addition, all subjects face a young and an old period during each life with
the latter characterized by higher health risks (probability of shocks), so our statistical analysis is
necessarily 2x2x2.
5

2.2

Model

This subsection presents the general model employed in our experimental design. We build upon
Grossman (1972) where resources are limited and can be allocated between enjoying life and
ensuring that it continues. Our subjects live for a maximum of T periods. They each have two
state variables: health Ht and savings St . Each period, health degrades by a fixed amount δ, and
is improved through an investment of ItH into health. Increasing health allows a subject to become
more productive, earn greater income and spend less time attending to ailments; thus, income
available to be spent by the subject during each period of the experiment is dependent on health.
Any income not invested on health or current consumption is deposited into a savings account
available for future consumption or investments in health. Subjects derive utility (which we refer
to as ‘joy’ in the subject interface) from current investments in joy ItJ . Joy is a concave function
of dollars invested in consumption, moderated by health, as being healthy allows one to enjoy life
more. Joy is our primary outcome and cumulative joy earned determines subjects payouts.
In addition to the standard elements of the Grossman model, we add the prospect of stochastic
negative health shocks, and two additional investments, resilience ItR and insurance ItI . Should a
shock occur that period, resilience investment reduces the magnitude of the shock, while insurance,
if purchased, will pay to recover any health lost due to the shock.
Listed below is the event timeline faced by subjects in our model. Each period, t, is subdivided into
the following four stages:

1. Investments I~t = ItH , ItJ , ItR , ItI withdrawn from income and savings.
2. Intermediate health Ht0 is determined for the current period considering health at the end of
last period, health degradation δ, health improvement R(Ht , ItH ), and whether a stochastic
health shock ∆t (ItR ) is realized.
3. Joy Jt (ItJ , Ht0 ) and period income M (Ht0 ) are computed based on investments and intermediate health.
4. ∆t (ItR ) health is recovered if insurance was purchased and a health shock occurred, yielding
a final health Ht+1 .
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Figure 1 shows the sequence of events each period and when health is at level Ht versus Ht0 . We
included the mid-period health experienced Ht0 so that subjects incurred a penalty from a shock
even if insurance was purchased in order to capture the real-life utility and income costs of health
shocks outside of medical bills. Placing insurance recovery at the end of the period is equivalent to
H , allowing for direct comparisons
a cash payout that is earmarked towards next period’s health, It+1

between insurance purchase and self-insurance through savings.1
2
Investment improvement
Fixed degradation
Shock realization

1
Investment decisions

3
Income earned
Joy received

4
Insurance improvent

Healtht+1

Healtht0

Healtht

Figure 1: Sequence of Events within a Period
The equations that govern the individual’s welfare maximization problem are:

Maximize:
P

J(ItJ , Ht0 )

(Lifetime Joy)

t=1,T

Subject to:
Ht0 = Ht − δ + R(Ht , ItH ) − xt ∆(ItR )

(Health Experienced)

Ht+1 = Ht0 + DtI xt ∆(ItR )
P
St + Itk = St−1 + M (H(t−1)0 )

(Health at start of next period)
(Budget constraint)

k

Where:
J(ItJ , Ht0 )is the joy realized in period t.
xt is the realization of the shock degradation random variable Xt ∼ Ber(µt ), where µt
is a fixed probability of a shock depending only on age.
ItI = DtI ρt (Ht0 , ItR , µt ), with DtI ∈ {0, 1}being the binary decision whether to purchase
insurance, and ρt (Ht0 , ItR , µt ) being the insurance premium that may depend on health,
shock size and shock probability.
1

The health improvement function is additive with investments so that if I is the cash equivalent insurance payout,
H
H
then R(Ht0 , I) + R(Ht+1 , It+1
) = R(Ht0 , I + It+1
)
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Functional Forms and Parameters
Below we delineate the specific functional forms we employed in the experiment in order to implement the general model discussed above. We begin with the functional forms of the joy, health
regeneration, resilience and income functions.

Jt (ItJ , Ht0 ) =

ItJ
Ht0
(γ + ItJ )

(1)

H

R(ItH , Ht )

=

eαIt
H

eαIt + (1 − Ht )/Ht

− Ht

R

(2)

∆(ItR ) = Φe−rIt

(3)

M (Ht0 ) = Ht0 Ωc

(4)

The joy function, Equation 1, has diminishing marginal returns to consumption, I J and moderates
joy realized by health experienced. The consumption term is asymptotic so that like the health
term it has an upper bound. The health regeneration function, Equation 2, is S-shaped logistic.
Improving health is least expensive at the middle of it’s range, and progressively more expensive
toward either end of the range. It is more expensive when health was high to model diminishing
marginal returns, and more expensive when health was low to model the complication of treating
co-morbid health issues. This specification also ensures that cost of increasing health remains the
same no matter how many periods the subject takes to do so. The shock moderation function,
Equation 3, imposed diminishing returns to investments in resilience, I R , the ability to moderate
the magnitude of shocks. The income function, Equation 4, was linear and increasing in health
experienced. Additionally, income depended on the subject’s base income type, low or high.
In the experimental environment that is used to implement this model, the subject lives at most 32
periods, but can die earlier. Health is restricted to values from 100 (perfect health) to 0 (death).
Life starts with health at 70 (H0 = 70) and depreciates by 8 (δ = 8) each period with certainty.
In addition, health declines further if there is a shock in a given period. The shock probability is
3/12 in the first half of life (µt = .25 for t ≤ 16), and 5/12 in the second half (µt = .4167 for
t > 16). The unmitigated shock was set to 25 health points (Φ = 25), but could be reduced to
8

as low as 12 through investment in resilience I R . We use Equation 3, but impose a maximum
investment per period and limit it to take on integer values. The shocks are pseudo-random. We
use 12 pre-generated shock sequences that rule out low probability sequences (< 10 and > 12
shocks/lifetime). Each subject receives a different shock sequence from life to life and and from
other members of a cohort with whom (s)he is allowed to chat.
To explore the heterogeneous impacts of insurance plans we create two types of variation in the
population. Subjects are either high- or low-income, with their type constant equal to the most they
could earn in any given period. Realized income for both types is their type constant multiplied by
their health. The constant Ωc for the high-income type was 200, 1.25 times greater than the one
for the low-income type, 160. While we refer to the income types as high and low, both types had
sufficient income to purchase insurance and might be better described as high and middle income.
For all levels of health below 35, the subjects received the minimum income, the same amount
as if they had a health of 35. For both income types we increase the probability of health shocks
during the second half of life when the subjects become old, creating an addition level of treatment
variation.
Under the ‘employer’ insurance plan, the employer paid 75% of the insurance premium cost, which
subsidy was fully funded through wage reductions that were universally imposed on all employees,
regardless of whether the individual chose to purchase the insurance. All employees were offered
the opportunity to purchase insurance at a fixed cost that was approximately 25% of the real cost
of insuring the average person in the employer’s pool. The constant deduction rate across incomes
(18%) meant that the system transferred contributions from high- to low-income subjects, while
the constant premium cost regardless of age transferred contributions from young to old subjects.
Calculations of exact amounts are in Table A.2. Our environment is mathematically equivalent to
an overlapping generations’ model.2
Under the actuarial plan, greater individual responsibility requires a complex and delicate dynamic
mix of savings, investments in resilience and health, and timely purchase of insurance. Moreover,
because they are unconstrained by an imposed employer tax and subsidy, individuals under the
2

Though we could have transferred subsidies from young to old within a period, we avoided the logistical complications of having subjects of varying ages participating simultaneously by pre-computing the actuarially accurate transfers
to that needed to be implemented.
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actuarial plan have the potential to obtain greater total welfare. Under the employer plan the discounted insurance premium funded by the salary tax predicts the universal purchase of insurance,
but reduced individual savings. In addition, the flat premium for all individuals under the employer
plan predicts moral hazard leading to reduced investment in resilience to shocks.
Under both insurance treatments, investment in resilience and the purchase of insurance are partial
substitutes for one another. Purchasing insurance negates the benefits of resilience in future periods
since any insured shock is immediately recovered from. However, resilience mitigates a shock’s
immediate impact on joy and income –insurance does not provide this benefit. Conversely, investing
in resilience reduces the value of the insurance. Under the actuarial treatment insurance and
resilience are also complements. Because insurance premiums are calculated to be actuarially fair,
conditional on purchasing insurance, the marginal cost of resilience is implicitly reduced as it also
results in lower insurance premiums.

Dynamic Programming Based Predictions
This environment is very complex and the optimal path through life is not clear. The combination of a finite lifetime of uncertain duration, stochastic health shocks, and dynamic interdependence across 5 possible investments, some with nonlinear profiles, make a closed form solution
intractable. Yet we regard this life course navigation task as less difficult than the behavioral
enterprise faced by human subjects needing to evaluate what, amongst the millions of investment/consumption decisions they will need to make during their lives and calculating today’s
marginal lifetime value of; doing 30 minutes more of exercise or not drinking a soda. Furthermore, as a surrogate for inter-generational and media based wisdom, we gave our subjects practice
lives and group chat, to aide them in navigating their decisions.
Lacking a closed form solution, we encoded a computerized stochastic dynamic program (DP) that
finds the optimal investment path for a subject by automatically readjusting to maximize expected
remaining lifetime joy given any possible shock sequence that might be encountered.
Figure 2 shows the mean optimal results generated by the dynamic program for the four treatment
groups. Red and orange lines plot the mean joy maximizing strategies in the employer treatment
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for high and low-income subjects, and blue and green do the same for the actuarial treatment.3 The
results derived from the mean investment choices made by optimizing agents reveal that optimal
strategies clearly depend on both insurance plan and income, and change dynamically through
life, and as shocks are encountered. We do not expect our human subjects to navigate the optimal
expected investment paths revealed in the DP figures, however, the mean optimal paths suggest
the qualitative properties of the dynamic paths that optimizing subjects responding to incentives
would follow. We employ the DP results to generate the theoretical predictions about the effects of
the two insurance treatments on subject behavior and how those interact treatments interact with
the income and life-stage treatments.
Insurance Purchase – Panel a plots the proportion of the 12 optimizing agents that purchase insurance in each period. The theoretical results generate two predictions with respect to insurance
treatment effects on the decision to purchase insurance:
Prediction 1: In the actuarial treatment, lower income subjects will purchase insurance
at higher rates than higher income subjects,4 but there will be no income effect in the
employer treatment where all subjects are always predicted to purchase insurance.
Prediction 2: Subjects offered the actuarial plan will purchase insurance about half the
time, and will be more likely to purchase insurance when they are very young with little
savings or very old; the short time horizon makes insurance a better value than resilience.
Resilience – Panel b plots mean resilience level to shocks throughout life.
Prediction 3: Within the actuarial treatment, subjects will increase their investments in
resilience in the latter half of life in response to the increase in the probability of a shock.
Prediction 4: Due to moral hazard in the employer treatment, subjects in this treatment
will not invest in resilience until near the very end of life. This is in sharp contrast to the
actuarial treatment, in which subjects invest in resilience at near maximal values when
old.
Health – Panel c shows health experienced by optimizing agents.
Prediction 5: Subjects in both treatments will increase health from the endowed starting
level and maintain a target level of health until the final 4-5 periods of life.
3
The somewhat jagged results occur because subjects are limited to discrete levels of investment, which can result
in sudden switches in optimal investment levels between compliments or substitutes especially when confronted with a
change in shock probability.
4
Optimizing actuarial agents tended to invest in resilience and self insure, thus did not purchase insurance unless
they encountered shock realizations that depleted the savings required for self insurance. This will occur more often for
low-income subjects.
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Figure 2: Results from Dynamic Program
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Prediction 6: There will be minimal differences in health levels across age, income or
insurance treatments.
Survival – Panel d shows the proportion of optimizing agents alive in each period.
Prediction 7: In all treatments, subjects will survive to the final period of life.
Savings – Panel e reveals that optimizing agents will transfer money from earlier periods to later
periods to smooth consumption and maintain health level, despite the increased shock prevalence
in the second half. The employer plan’s pricing reduces the need for a subject to save.
Prediction 8: In both insurance treatments, savings will increase in the first half of life
and then decrease in the second half of life.
Prediction 9: Savings will be about four times higher in the actuarial than in the employer
treatment, exceeding 100 at midlife.
Joy – Panel f shows optimizing agents largely smooth joy across life. Joy investments are low in the
beginning of life when the priority is increasing health and future income. Conversely, at the end
life joy investment is increased:
Prediction 10: For high income subjects, joy obtained will be higher in the actuarial
treatment than in the employer treatment throughout life, and substantially higher in
aggregate.
Prediction 11: For low income subjects, joy obtained in the employer treatment will be
higher during the first half of life, but lower during the second half of life. In aggregate
total joy obtained by low income subjects in the actuarial treatment will be marginally
higher.

2.3

Experimental Interface

Figure 3 shows the experimental interface seen and manipulated by the subjects. The heart icon
represents health, the happy face denotes joy, and the money icon cash. The row above of the
small table shows the present values of health and accumulated joy, and the income the subject
will receive this period. The two rows in the table show the resulting health, marginal joy earned,
and balance of the savings account at the beginning of next period given a shock is not or is
encountered. Money can be allocated to health or joy by moving the respective sliders below the
graphs in the top center. The graphs allow the subject to see the diminishing marginal returns of
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both investments. Subjects make insurance and resilience decisions by checking boxes below the
graphs. Remaining budget and potential outcomes update dynamically with each decision. Any
unallocated money is automatically saved, and added to income next period.5 Subjects were paid
based on the sum of joy received across all periods and lives.
Figure 3: Subject Interface

During the shock stage of the period following the investment stage, the shock wheel in the upper
left corner spins. If the pointer lands on the darker section with the storm cloud icon, the subject
receives a shock. The darker shock section of the wheel is proportionately larger during the second
stage of life indicating the increased probability of a shock. The lower lines in the investment
graphs indicate diminished values when a shock occurs. The outcome stage of the period is when
the subjects receive both joy and income. It was temporally separated to make it clear that both
were based on the subjects’ health, including reductions from any shock received during that period.
In the final stage, if the subject had bought insurance that period, health was restored to its preshock level. If the subject was uninsured or self-insuring through savings, they could only pay to
restore their health in the first stage of the following period.
Subjects are organized into groups of four individuals with the same income type. The right side
5

Saving was possible for any number of periods, but not across lives. Any savings held at the end of a life were lost.
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of the screen shows the group history for the present life. There are graphs for health, cumulative
joy, and budget. Each graph has a colored line for each group member that corresponds with the
member’s title color and label. The bottom right corner displays each group member’s resilience
history in a heat map style table, with superimposed dots indicating insurance purchase decisions.
The numbers in the shields below the table indicate resilience levels corresponding to color density.
The colored coded tables at the bottom left reveal the current status of each group member. The
umbrella icons indicate being currently insured.
Subjects could choose whether to chat with other group members through text. The bottom center
is the chat section. Chat is available at all times including in pauses between lives. Even though
subjects can chat, subject payouts from the experiment depend solely on individual performance.
There is no financial reward to sharing information, nor is there any incentivized competition giving
reason to withhold information.
After thorough on screen and audio instructions, subjects participate in three practice lives of 4, 16
and 16 periods, before engaging in the two longer 32 period lives that we analyze. Subjects are
paid for all periods of all lives. A subject who dies (i.e. Health = 0) in any particular life must wait
until all the other subjects in the experimental session complete that life, but can chat with other
group members and observe all their actions.

2.4

Procedures

We ran 12 experimental sessions at the Economic Science Institute (ESI) Lab at Chapman University
between April 24th and May 16th , 2018. Eight sessions had 24 subjects, two had 20, one had 16 and
one had 12.6 Subjects were recruited via email from a database of subject volunteers ESI maintains.
Sessions lasted 120 minutes. Average subject earnings were $36.79, including the $7 show-up fee.
Table 1 shows the 2x2 treatment design and number of subjects in each cell. We analyze 64 periods
(two 32-period lives) for each subject, yielding over 4,000 observations per cell.
Table 2 lists insurer details by treatment. The insurance premium charged in the Actuarial treatment was the expected cost of treating the shock plus 10% (to model administrative costs). The
6

When there were fewer than 24 subjects, the number of subjects was a multiple of four so that all subjects had
equal-sized groups. The subjects, who remained after the maximum number of groups of four was formed, were paid a
show-up fee and allowed to depart.
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Table 1: Subjects per Treatment Cell
Treatment
Actuarial Employer
Low-Income
High-Income

64
64

68
64

insurance premium was always $9 in the Employer treatment, however subjects in the Employer
treatment received only 82% of the base income they would have received in the Actuarial treatment. The ‘employer’ uniformly decreased wages by 18% in order to fund the insurance subsidy it
provided plus pay the insurer.
Table 2: Treatment Details
Actuarial

Employer

1.1 * E(Costit )
100%
0
442

$9
82%
654
259

Total Revenue
Benefits Paid

442
409

913
865

Insurer Profit
Profit Rate

$32
7.3%

$48
5.2%

Premium
Subject Income
Withheld Income
Premiums Collected

Insurer revenue is defined as the sum of all premiums paid (in both treatments) plus all income
reductions to subjects (in the employer treatment). Profit is defined as revenue minus the total
amount paid to the subjects to recover from insured shocks.The profit rate is the profit divided
by the revenue.7 Values reported are per subject lifetime. The actuarial treatment had a slightly
lower profit rate (7.3%) than designed, because, by chance, the stochastic shock rate on the periods
when subjects did not buy insurance was lower than the rate during periods when insurance was
purchased. The insurer profit rate in the employer treatment (5.2%) was slightly lower than in the
actuarial treatment, however, the revenue stream was larger due to much increased subscription, so
overall the insurer made more profit under the employer plan ($48) than the actuarial plan ($36).
The table demonstrates that the subsidies under the employer plan were completely funded, and
no ‘external’ resources were required.
7

Row5 = Row3 + Row4, Row7 = Row6 − Row5 and Row8 = Row7/Row5
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2.5

Data Analysis

Our regressions on insurance purchase and survival will use a panel data probit model:

Yit = Π(φi + τi + νi + εit )

where φi is a vector of sub-population binary variables indicating the subject’s age within the
experiment life {young, old} and income type {low, high}; τi is vector of binary variables indicating
belonging to a particular sub-population and being in the employer-based insurance treatment; νi
is an individual error term; and εit is period and subject specific error term. Errors are clustered
according to which shock sequences (there were only twelve) the subjects experienced.
Our regressions on resilience, health, savings and joy will use a panel data model:

Yit = φi + τi + νi + εit

where the variables have the same specifications, but there is no link function.

3

Results

Figure 4 presents temporal plots of mean subject data by treatment. Red and orange lines plot
behavior in the employer treatment for high and low-income subjects, and blue and green plot the
actuarial treatment. (Table A.1 of the Appendix provides the summary statistics for the subject
data plotted.) We use the plots to render subject behavior in the environment before proceeding to
regression analysis of the differences across populations and treatments.
Insurance Purchase – Panel a shows, that nearly all subjects of both income groups in the employer
treatment purchased insurance every period except the last one or two. Under both insurance
treatments, low-income subjects purchased insurance at greater rates than high-income subjects.
Resilience – Subjects invested more in resilience in the actuarial than in the employer treatment,
and investments in resilience increased in the second half of life when the shock rate increases
(Panel b).
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Figure 4: Results from Subjects
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Health – Subjects maintained relatively high levels of health throughout midlife (Panel c). However, in all treatments health tapers off sooner during the second half of life. This results in lowered
incomes throughout life because and less joy realized during later periods of life. The effect is more
pronounced for subjects in the actuarial treatment, especially low-income subjects.
Survival – Panel d shows some subjects died due to under-investments in health and resilience,
especially in the low-income actuarial treatment in which 20% died.
Savings - Subjects in the actuarial treatment saved more than those in the employer treatment, and
high-income subjects save more than low-income subjects (Panel e).
Joy – As was achieved by the optimizing agents, Mean joy is higher in the actuarial than in the
employer treatment for higher income subjects, especially during the first half of life (Panel f).
However, in contrast, low-income subjects realized less joy in the actuarial than in the employer
treatment, particularly during the second half of life.

3.1

Regressions on Treatment Period Differences

Table 3 reports regression results that provide statistical tests of the treatment differences illustrated
by the results graphs. The six table columns labels (a-f) correspond respectively to the six panels in
the result graphs. For all columns, estimates are reported for seven binary indicator variables. The
first three variables represent the four sub-populations resulting from interacting age and income
(low-income young is the omitted sub-population), so each variable provides an estimated impact
of belonging to that sub-population relative to the omitted one. The remaining four variables indicate both belonging to a particular sub-population and being in the employer-insurance treatment,
so they estimate specific effect (of employer-insurance) for each of the four sub-populations.
Insurance Purchase – Column (a) of Table 3 presents estimated marginal effects of a probit regression on insurance purchase. In the actuarial treatment, the low-income, young subjects purchase
insurance at the highest rate, because they are most vulnerable–less able to afford resilience or to
self insure through savings. The difference between the purchase rate and each of the other three
sub-populations is statistically significant, as is reported in the first three rows.
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Table 3: Regression Estimates for Baseline Differences and Treatment Effects

VARIABLES
Low Income Old
High Income Young
High Income Old
Emp * Low Young
Emp * Low Old
Emp * High Young
Emp * High Old

(a)
Ins. Purchase

(b)
Resilience

(c)
Health

-0.0760***
(0.0201)
-0.150***
(0.0364)
-0.0852***
(0.0262)
0.372***
(0.0362)
0.408***
(0.0340)
0.414***
(0.0293)
0.352***
(0.0258)

0.532***
(0.0886)
0.0991
(0.0950)
0.676***
(0.0966)
-0.692***
(0.0496)
-1.144***
(0.0716)
-0.711***
(0.0863)
-1.124***
(0.0847)

-13.14***
(1.669)
3.132*
(1.656)
-4.008
(2.591)
2.410
(1.797)
8.401***
(2.579)
-2.103*
(1.267)
-0.481
(2.138)

Observations
16,640
16,640
16,640
Sequence Controls
Yes
Yes
Yes
Log Likelihood
-6139
Rho
0.513
0.467
0.461
P-value
< .001
< .001
Number of Subj. Lives
520
520
Clustered (on Shock Sequence) standard errors in parentheses

(d)
Survival

0.117**
(0.0527)

0.127***
(0.0244)

0.0224
(0.0686)
455
Yes
-127.9
0.0949

(e)
Savings

(f)
Joy

-1.542
(3.169)
5.692**
(2.649)
1.373
(2.881)
-5.645
(3.739)
-7.906***
(2.897)
-15.61***
(1.925)
-10.81***
(1.619)

-22.10***
(2.788)
25.93***
(2.006)
10.15**
(4.136)
-3.016
(2.303)
11.62***
(2.743)
-8.239***
(2.336)
0.252
(3.803)

16,640
Yes

16,640
Yes

0.612
0.220
< .001
< .001
520
520
*** p<0.01, ** p<0.05, * p<0.1

Result 1: F As predicted, within the actuarial treatment, low-income subjects. (The
estimate in row 2 is negative and the estimate in row 3 is less than row 1.)
Result 2: As predicted, in the employer treatment, subjects are (35 to 41%) more likely
to purchase. (Rows 4 to 7 provide estimate effect for each type.)
Resilience – Column (b) of Table 3 reports coefficient estimates from a linear regression on resilience (ordered probit results are in the appendix table A.3).
Result 3: As predicted, subjects in the actuarial treatment increase resilience during the
second ‘old’ half of life (rows 1 and 3 are positive), but much less than predicted (the
values are less than 1).
Result 4: Consistent with predicted moral hazard, resilience is lower in the employer
treatment. (Rows 4 to 7 are all negative). F However, the difference is smaller than
predicted.
Health – Column (c) of Table 3 reports coefficient estimates from a linear regression on health.
Health is dramatically lower, over 13 points, for low-income old subjects. Health was maintained
by all sub-populations at lower levels than counterpart optimizing agents.
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Result 5: F Contrary to the DP prediction, subjects do not increase their health from
initial levels. Subject health declines as predicted in the end of life, though to a smaller
magnitude.
Result 6: F In the actuarial treatment, there are larger than predicted health disparities between high and low income subjects. For young subjects high income produces
significantly higher health (row 2 is positive), and for old subjects high income produces
dramatically higher health (row 1 is large, negative and statistically significant, while row
3 is not different than 0). The employer treatment largely diminishes these disparities for
both low income (adding row 5 to row 1 is -4.74, only about a third of row 1) and high
income subjects (the sum of rows 6 and 2 is nearly 0).
Survival – Column (d) of Table 3 reports probit estimates on whether the subject was alive at the
end of the 32 period life, so there are no estimates for young subjects. Sixty-five subject lives were
dropped from the regression because their innocuous shock sequences perfectly predicted survival.
Result 7: The survival rate across all subjects was 91% whereas no optimizing agent failed
to survive.
A) Under the actuarial treatment, being high-income increased a subject’s chance of
survival by 11.7% (row 3).
B) F Employer insurance closes the income survival gap (row 3 and 5 are nearly
equally) as fewer low-income subjects die prematurely, without significant impact
on the survival of high income subjects (row 7 is near 0).
Savings – Column (e) of Table 3 shows regression estimates of how savings differed by subpopulation. Only the high-income young had a statistically significant difference in savings. The
employer treatment reduced savings for all four sub-populations, but the reduction for low-income
young subjects was not statistically significant.
Result 8: F Contrary to the DP prediction, subjects in all treatments did not accumulate
substantial savings throughout the first half of life in order to smooth health and consumption during the second half of life. Subjects saved for the first couple of periods,
achieved some (relatively low) savings target, and then maintained that low level target
until midlife, after which they slowly dispensed their savings.
Result 9: F This lack of savings for future use was especially dramatic in the actuarial
treatment. While the regression coefficients are statistically significant, their magnitude
is too small. Savings was only a fraction of what was required to smooth health and
consumption.
Joy – Column (f) reports estimated differences in joy obtained within periods. Young subjects earn
more than old, and high-income earn more than low-income.
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Result 10: As predicted, for high-income subjects, the employer treatment reduces joy
obtained when they are young (row 6). F However, contrary to the DP prediction, there
is no impact on joy obtained when subjects are old (row 7).
Result 11: F Contrary to the DP prediction, low income subjects in the employer treatment obtained joy equal to those in actuarial early in life, and then surpassed them later
in life (row 5).

3.2

Insurance Treatment Effect on Lifetime Joy

Table 4 provides regression estimates of the cumulative effect of employer insurance on lifetime
Joy over the 32 periods of life by income category.
Table 4: Coefficient Estimates from Regressing Cumulative Joy on Insurance Type

VARIABLES
Employer

(1)
Low Income

(2)
High Income

(3)
All

137.7*
(72.75)

-127.8
(90.03)

-5.127
(76.43)

Observations
264
256
520
# of Subjects
132
128
260
Robust standard errors in parentheses
*** p<0.01, ** p<0.05, * p<0.1
Result 12: F Contrary to the DP prediction, the employer treatment reduces lifetime
Joy disparity (column 1 is positive), without a statistically significant impact on aggregate
population Joy (column 3 is not statistically significant).
Contrary to the DP prediction that welfare will be higher in the actuarial plan because subjects were
unconstrained by an imposed employer subsidy/wage contribution, welfare was actually higher in
the employer plan. Table 5 investigates this inconsistency, comparing mean joy subjects earned in
the Actuarial and Employer Treatments to mean joy earned by optimizing agents (the DP means).
It confirms significant interaction between income and insurance treatment in obtaining joy. Highincome subjects obtained more joy in the actuarial than in the employer treatment, but contrary
to the optimizing agents, low-income subjects fared absolutely better in the employer than in the
actuarial treatment. As such, differences in obtained joy between low and high-income subjects
were significantly greater in the actuarial than in the employer treatment, with low-income subjects
obtaining 73% of the joy high-income subjects obtained in the employer treatment, but only 64%
in the actuarial treatment. Similarly, if we compare, efficiency, subjects’ performance relative to the
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mean of the optimizing agents, low-income actuarial subjects are the clear outliers, obtaining only
69% of their optimizing counterparts’ joy, whereas the other three groups achieve 76% ± 1%.
Table 5: Mean Joy Obtained

Subject
Employer
Actuarial
Emp/Act

4

1816
1679
1.08

Low Income
Optimal Efficiency
2391
2423
0.99

0.76
0.69

Subject
2482
2609
0.95

High Income
Optimal Efficiency
3213
3462
0.93

0.77
0.75

Low/High
Subject Optimal
0.73
0.64

0.74
0.7

Discussion

Taken together, these results show that subjects were sensitive to the differential incentives in the
actuarial and employer treatments. In the employer treatment, subsidies did provide an incentive
to purchase more insurance (Result 1), and its fixed cost, regardless of subject behavior, reduced
investments in resilience, supporting the moral hazard prediction (Result 4). However, subjects in
both treatments under-invested in the future in favor of current consumption. In aggregate, subjects spent 10.7% more of their budget on current consumption than was optimal, as determined
by the DP optimizing strategy, given the period, present budget and health. This is evident in the
underinvestment in savings (Result 9) and in health early in life by subjects in both the employer
and actuarial treatments (Result 5). Moreover, in the actuarial treatment, subjects also underinvested in resilience (Result 4), undervaluing the marginal effects of resilience in reducing the size
of a health shock, and failing to respond to incentives in insurance pricing.
The under-investment in the future and over-investment in current consumption had greater impacts on total joy obtained in the actuarial than in the employer treatment. Investments in savings
and resilience are more critical to obtaining joy in the actuarial treatment: savings, because insurance costs increase in the second half of life, when the shock probability becomes higher; and
resilience because insurance premiums vary negatively with investments in resilience. The flat lifetime rate for insurance in the employer treatment both obviates the need for significant savings and
provides little incentive for investments in resilience.
Figure 5 show the implications of subjects’ lack of investment in their future, plotting Joy lost
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relative to optimal, and how those losses accrue across life. Results for high- and low-income
subjects are presented in Panels a and b, respectively. Within each panel, the blue bars plot actuarial
values and the red bars plot employer values. For each subject in each period of all experiments,
we used the DP to calculate the best and worst decisions that the subject could make in her effort
to maximize joy over the remainder of her life, taking into account her current health and savings.
Including the total joy actually earned in all previous periods, the top of each period-bar (‘optimal
play’) shows the mean total lifetime joy that subjects could obtain by making the best possible
decision in that period and then playing optimally for the remainder of life. The bottom of each
period-bar (‘pessimal play’) shows the mean total lifetime joy that subjects could obtain by making
the worst possible decision in that period but then playing optimally for the remainder of life.
The bold line within each period-bar corresponds to the mean observed actual play. The total
height of the period-bar shows the loss in lifetime joy between making the best and worst decisions
that period. Finally, the dotted lines in the red employer bands show the higher mean expected
aggregate joy with a pessimal decision, conditional on subjects always buying subsidized insurance.
Subjects’ decision efficiency –the bold line position within the bar– is relatively constant and much
closer to optimal than pessimal, but by the end of life a significant proportion of potential lifetime
joy has been lost to compounding small errors.8 As life progresses potential aggregate joy in the
actuarial treatment decreases more than in the employer treatment. This impact is much larger for
low-income subjects for whom the actuarial bars start above the employer bars but quickly fall and
stay below, revealing the greater cost of non-optimal decisions. The height of the vertical periodbars is greater for the actuarial treatment than for the employer treatment for both income levels,
indicating a greater potential for costly errors in decision making, and this comparative difference
becomes even more exaggerated if the bottoms of the employer period-bars are limited by the
dashed (buy employer insurance) decision.
The under-investment in the future and over-investment in current consumption had greater impacts on total joy obtained in the actuarial than in the employer treatment. Investments in savings
and resilience are more critical to obtaining joy in the actuarial treatment: savings, because insurance costs increase in the second half of life, when the shock probability becomes higher; and
8
Aggregate attainable lost joy is ∼ 25% for high income, actuarial subjects, ∼ 22% for high income, employer subjects,
∼ 32% for low income actuarial subjects, and ∼ 23% for low income employer subjects.
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Figure 5: Joy Earned by Subjects Compared to Optimal
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resilience because insurance premiums vary negatively with investments in resilience. The flat lifetime rate for insurance in the employer treatment both obviates the need for significant savings
and provides little incentive for investments in resilience. The optimal strategy in the employer
treatment varied relatively little across life, with two exceptions. The first eluded most subjects,
and was their most costly deviation; not spending more to increase health in the first few periods.
Once the higher health was achieved, spending could be reduced to maintain that level. The other
was to shift some health spending to joy at the end of life, which the subjects did to some extent.
In contrast, decision in the actuarial environment were more complicated; optimal contributions
change dynamically across life and necessitated weighing inter-temporal trade-offs across multiple
interdependent investments. Optimal savings would require calculating and comparing the expected marginal value of spending in each period. To recognize the value of resilience, subjects
needed to aggregate its multiple returns. Higher resilience meant higher health in the event of
shock. That had an immediate return in more joy as well as less costly recovery and more income.
The latter two benefits also had value that compounded over all future periods. This environment
combined with subjects’ present bias in decision making had deleterious welfare.
The greater deviation between the predicted and observed behavior in the actuarial treatment
suggests that its increased complexity, reduces subjects’ abilities to optimize their choices. Our
findings are also consistent with research finding poor public comprehension of health insurance
a strong preference for simpler plans (Loewenstein et al., 2013). Of particular significance, is that
the individual responsibility required by the actuarial plan was particularly detrimental to the lower
income subjects. Our results are consistent with a related literature, originating with Iyengar and
Lepper (2000) and summarized by Chernev et al. (2015), showing the number of choices negatively
impacts on quality of choice. It is also consistent with the literature on laboratory experiments in
which individuals must make dynamic decisions in multi-period lives (Ballinger et al., 2003, Gillet
et al., 2009, Carbone and Infante, 2014, 2015). Given that less than 3% of Americans follow four
major guidelines for healthy behavior Loprinzi et al. (2016), our general findings are consistent
with empirical patterns observed in the real world.
We note that our subjects in the low-income actuarial treatment purchased more insurance than
those with higher income, as predicted by the DP optimizing agents. This apparently reflects a
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greater gain from buffering risk as income and health decrease with age in our environment. This
experimental result seems somewhat contrary to observational field data findings in which lowincome individuals are less likely to be insured. (Berchick et al., 2018). Though low-income subjects insured at higher rates, they maintained lower resilience relative to high-income subjects, so
they were correctly allocating given their variation in marginal benefits. We do not know, however,
if an even lower income treatment would have reversed this effect. One potential implication of our
result is that low-income individuals in the world outside the laboratory are less risk sensitive than
our subjects. More likely may be that impediments to the purchase of health insurance, such as
strong financial constraints, income interruption, under-forecast expenditures, and difficulties interacting with governmental agencies, may better explain SES effects on health insurance coverage
than insensitivity to risk. Such effects may force lower income people to insure through informal
mechanisms, even at considerable expense, to prevent the extremely harsh consequences that a
negative health shock would cause them (Banerjee and Duflo, 2007). This issue certainly deserves
further experimental investigation.
The limitations of our study should be considered in interpreting these results. First, virtual ‘health’
in an experimental environment may be experienced very differently than real-world health. Behaviors, such as diet, exercise, and tobacco, alcohol and drug use, may be experienced and motivated
differently than moving levers to pay for improved health in an economics laboratory. What is very
encouraging, however, is that our subjects’ behavior matched most of the qualitative predictions
of the DP optimizing agents, and deviations from optimal behavior, such as under-investment in
health and resilience throughout life, are commonly observed in the real world.
Another limitation is that actuarial subjects in our experiment were not precisely informed about
how insurance price was calculated: they were simply told they would have the option buy insurance and their current price would be shown on their screen. However, from period to period
subjects could easily see that insurance price increased/decreased with the rise and fall of their
investment in resilience.
All subjects were endowed an initial health stock of 70/100 in their first period of life. We knew
that in all cases this was below the level optimizing agents would hone in to. Many subjects
tended to maintain this initial stock with small deviations (±5) from period to period until the
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endgame in which they allowed it to deteriorate. It is unclear whether they would have maintained
a higher, ‘near optimal’ level of 75-80 if that were their initial allocation, or whether and how
quickly they would have allowed their health to deteriorate if their initial stock was higher than
optimal. However, the experiment had three training lives and chat groups with complete public
information on like-subjects’ behavioral choices. This allowed the subjects to jointly explore their
strategy space, prior to the 32 period lifetimes that generated our data. These factors suggest that
the behavioral proclivities we observed are not due to an anchoring effect.
Assessments of the experimental environment’s validity with respect to actual health behavior will
be necessary for evaluating the productivity of this approach. Two future experiments we plan
to implement to test validity are: 1) perform multi-day experiments that substitute real-effort,
accelerometer-measured exercise, for investments in resilience while maintaining other features of
the current experimental protocol; and 2) conducting the experiments with other ethnic and SES
groups as opposed to university students to evaluate the generality of our findings.

5

Conclusion

Our results have theoretical, policy and methodological implications. Even though under optimal
play the actuarial plan had higher potential life satisfaction, we find that it did not outperform the
employer plan in our experiments. The gains in efficiency due to individual responsibility under the
actuarial plan were very modest for high-income subjects and non-existent for low-income subjects.
All actuarial subjects under-invested in savings and resilience to shocks, compared to optimizing
agents. Low investment in resilience (fitness) also observed in the actuarial treatment suggests
that concerns about moral hazard are overemphasized in policy debates. On the other hand, the
employer plan resulted in a simpler decision space and significantly reduced observed disparities
due to income level and phase of life. Thus, in this environment, the advantages of risk-sharing and
income transfers appear to outweigh the gains from incentives for individual responsibility. Might a
hybrid system such as: an employer-based system with appropriate premium incentives for healthy
behavior outperform the two systems we investigated here?
The findings from this experiment illustrate the benefits of the experimental laboratory, as a com-
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plement to existing research methods. This method allows us to simulate a complex, multi-variate
dynamic health decision environment and assess the lifetime population effects that might be imposed by individual health behaviors. At the same time, it permits controlled experimental manipulations of policy alternatives where evaluation is not impeded by selection biases. A major
challenge that confronts this experimental approach is whether it can be applied with validity to
real-world health behavior. Validity assessment is a clear next step, but the results obtained so far
are encouraging as they qualitatively match observed real behavior.
There is ample scope for mutual translation from such experiments to observational research and
real policy manipulations. Hypotheses generated from population-based studies could be tested
with controlled laboratory experiments, and findings from laboratory studies can motivate new
analyses of population data. Such experiments can be used to explore whether policies under
consideration will result in expected effects or have untoward and unexpected consequences. Similarly, the results of existing policy experiments, such as Romneycare and the ACA, can inform new
experimental treatments to isolate causality and to assess modified policy alternatives.
More broadly, the experimental environment can be adapted to address other issues in which observational studies were unable to reach conclusive findings due to insufficient data or co-linearity
of important variables. There is the potential to disentangle, for example, the relationship between education and health, as well as conduct experiments addressing chronic disease and how
social norms and learning impact health decisions. These factors potentially interact with insurance policy. We advocate that experimental test environments like ours are a low-cost alternative
to understanding these nuances of health behaviors before proceeding to much more costly field
studies and wholesale policy changes.
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Appendices
A.1

Summary Statistics

Table A.1 presents the descriptive statistics regarding subject decisions and outcomes for the four
experimental treatments in the first and second halves of life.
Table A.1: Summary Statistics

Insurance Purchase
Resilience
Health
Savings
Joy
Income

Low Income
Actuarial
Employer
Young
Old Young
Old
0.61 0.60a
0.94 0.98a
0.78
1.48
0.07
0.15
63.91 56.16 64.42 57.61
15.92 12.46
9.91
6.11
79.75 82.16 79.75 82.16
102.31 94.79 83.33 78.09

Average Lifetime
Premature Deaths
a Excluding last period.

A.2

29.4
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High Income
Actuarial
Employer
Young
Old Young
Old
0.40
0.51a
0.88
0.94a
0.86
1.48
0.15
0.33
65.36
60.05
63.79
60.13
21.04
16.29
5.51
5.00
79.75
82.16
79.75
82.16
129.52 124.64 103.33 100.63

31.9
5

31.4
9

31.1
7

Transfers

Table A.2 provides calculations of the transfers in the employer based insurance. Profit (π) per
period for each group of subjects is the Insurer’s “Payout” less Withheld (from subjects’ income)
and Premium paid. Sum-zero subtract one quarter of $6.43 of insurer profit from each group. This
column sums to zero and is the inter-group transfers. Mean transfers from young to old are $7.65,
and $3.60 from high- to low-income.
Table A.2: Transfer Calculations
Group

Payout

Withheld

Premium

π/period

Sum Zero

Low Inc. Young
Low Inc. Old
High Inc. Young
High Inc. Old

21.54
36.51
19.43
32.26

19.43
17.73
23.7
22.45

8.46
8.46
7.9
8.05

-6.34
10.32
-12.17
1.76

-4.74
11.93
-10.56
3.37

Total

109.75

83.31

32.87

-6.43

0
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A.3

Supplemental Regressions

Table A.3 report coefficient estimates and level cut points from ordered probit regressing Resilience
on insurance type, as robustness check to the regression on resilience as continuous variable, reported in the main text. Estimates are consistent with the continuous version. In all cases employer
insurance reduces resilience.
Table A.3: Estimates from Ordered Probit Regressing Resilience on Insurance Type

Employer
/cut1
/cut2
/cut3
/cut4

(1)
Young
Low Income

(2)
Young
High Income

(3)
Old
Low Income

(4)
Old
High Income

-1.217***
(0.0971)
0.408***
(0.0579)
0.708***
(0.0617)
1.232***
(0.0853)
1.647***
(0.0954)

-1.283***
(0.100)
0.0527
(0.0770)
0.259***
(0.0764)
0.662***
(0.0518)
1.094***
(0.0575)

-1.090***
(0.110)
0.181*
(0.0940)
0.638***
(0.0856)
1.148***
(0.0905)
1.850***
(0.136)

-1.154***
(0.0861)
-0.216***
(0.0799)
0.0874
(0.0579)
0.606***
(0.0786)
1.286***
(0.110)

4,096

4,096

Observations
4,224
4,224
Robust standard errors in parentheses

*** p<0.01, ** p<0.05, * p<0.1

A.4

Results Summary

All treatment effects, for both optimally computed (DP maximizers) and observed (human subjects), are summarized in the following tables: In both tables, sign denotes direction of effect,
number of signs denotes size of mean effect relative to its range and variation. Blank cells indicate
no meaningful effect. Survival is calculated only for the old. Table A.4 reports difference between
DP joy maximizers and the human subjects.
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Table A.4: Effect Size, (DP Maximizers - Human Subject)
Income
Type

Ins. Type
Age

Insurance
Purchase

Resilience
Investment

Health
Investment

Low

Act/Yng
Act/Old
Emp/Yng
Emp/Old

+
--

++

+
++
+
++

Survival to
period 32
+++
+

Total
Savings

Total Joy
Consumed

+++
+++
+
+

+++
+++
++
++

Act/Yng
++
+
+++
++
Act/Old
-+++
++
+
+++
++
High
Emp/Yng
++
++
Emp/Old
+
++
++
Legend: sign notes direction. -/+ small but meaningful,- -/ ++ moderate, - - -/+++ large difference

Table A.5 has three sections. In each section, there is a column for the within DP joy maximizer
comparison and a column for the within human subject (HS) comparison. The top section reports
the differences between the employer and actuarial treatments. The middle section reports the
differences between old and young. The bottom section reports the difference between high- and
low-income.
Table A.5: Effect Size for All Treatment Comparison
Insurance
Purchase

Resilence

Health

Compare

Subgroup

DP

HS

DP

HS

Emp-Act

Yng Low
Old Low
Yng High
Old High

++
+++
+++
+++

++
++
++
++

----

-

Act Low
Act High
Emp Low
Emp High

----

+

++
++
++
++

+
+

Old-Yng

DP

HS
+
++
-

Survival
DP

HS
+++
+

+

-

---

Savings

Joy

DP

HS

DP

HS

-----

-

--

+
--

-

++
+
+

++
+
+
+

Act Yng
--+++ +
+
+
+
+ +++ +++
Act Old
++
+
+ ++
+++
+++ +++
High-Low
Emp Yng
+
+
+
+
+++ +++
Emp Old
+
+
+
+
+
+ +++ +++
Legend: sign notes direction. -/+ small but meaningful, - -/ ++ moderate, - - -/+++ large difference
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A.5

Decomposition

Moral Hazard and Joy Transfers – Subjects under the Employer treatment (especially Lowincome) were able to perform relatively better, compared to maximizers, than their actuarial counterparts. This indicates that the subsidies and implicit transfers provided under the employer plan,
from high to low-Income and from young to old subjects, are having a marked effect even though all
subjects tend to underinvest in resilience. Because actuarial insurance bases its premiums on individual subject resilience and health, there is by definition no moral hazard and no welfare transfers
between categories of actuarial subjects. But considering the degree to which the actuarial subjects
fall ‘behaviorally’ short of optimal resilience investment, we can assume that that employer subjects
underinvesting to any greater extent are falling subject to moral hazard.
The mean percentage by which actuarial subjects underinvest in resilience was 54%. Premiums in
the employer insurance treatment were pre-calibrated to be profitable despite anticipated underinvestment in resilience. To measure subject-induced moral hazard under the employer treatment,
we simply calculated the insurer’s expected profit and the subjects’ expected joy for every level
of health and resilience the subject could have had. We then calculated how much the insurance
company could have transferred to the maximizer/subject conditional on her investing in each resilience level in order for the insurer to have the same expected profit as it does when subjects have
a fitness of 0. Finally, we calculated how much more expected joy the subject could have earned
with the conditional transfer. We defined potential moral hazard costs as the gain in expected joy
between a subject’s optimal resilience level and observed (mean) levels in actuarial subjects. We
then calculated how high expected joy level would have been if there were transfers and the subjects maintained the fitness level that actuarial subjects maintained, which was 46% of the potential
moral hazard cost. The balance, 54% of the transfer benefits, can be attributed to the behavioral
proclivity to underinvest in resilience, even when there are incentives to invest, as in the actuarial
treatment.
Using this information and mean expenditures on the various possible investments, Table A.6 below
decomposes the mean components of joy obtained under the employer treatment, relative to the
actuarial treatment, by considering the insurance subsidies provided and received.
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Table A.6: Employer Subjects’ Decomposition of Joy Obtained
Low Income
DP
Subjects
Actuarial Joy
Selection Bias
Transfer Young → Old
Transfer High → Low
Admin Fees
Moral Hazard
Health Modified Joy
Death Prevention Joy

High Income
DP Subjects

2423
0
-31
99
-27
-80
0
0

1679
0
4
66
-21
-57
27
173

3462
0
-25
-75
-37
-96
0
0

2609
0
1
-112
-14
-63
23
11

Total Adjustments
(% Actuarial Joy Obtained)

-39
(-1.6%)

193
(+11.5%)

-233
(-6.7%)

-154
(-5.9%)

Residual Joy
(% Actuarial Joy Obtained)

-21
(0.3%)

-56
(-8.2%)

-16
(-0.5%)

27
(+4.9%)

2391

1816

3213

2482

Employer Joy

The first line of Table A.6 shows the mean joy amounts at the end of life for the each income
group in the actuarial Treatment. The last line shows the corresponding means in the employer
treatment. Each intermediary line is the estimated impact of one difference between treatments.
We saw no selection bias in the employer treatment, neither in the DP nor human subjects, meaning
young and old purchase insurance at near identical rates. The third line reports estimates for the
benefit of consumption smoothing from the transfers from young to old netted across life. The
human subjects benefit mildly from these. The DP is actually hurt by the transfers. The DP has
the foresight to save to smooth consumption, so the imposed transfers constrain its ability to adjust
savings according to the stochastic shock pattern experienced. The fourth line reports the estimated
impact of the transfers from rich to poor: the effects are strong and all in the correct direction. The
administration fee line is the estimation of the cost in joy to the employer subjects of the profit the
insurer extracts. Moral hazard is the estimated impact on joy of maintaining resilience at a lower
level, which may be individually optimal but socially costly. The Health Modified Joy line is the
estimate of how much higher health in the Employer versus actuarial treatment benefits subjects
by increasing their joy: DP maximizers do not display this effect. The Death Prevention Joy line
is the estimate of how much extended life in the employer versus actuarial treatment benefits
subjects by increasing their joy: again, DP maximizers do not display this effect. The Residual Joy
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is the unexplained difference between observed joy in the actuarial and employer treatments after
accounting for the Total Adjustments.
Subjects - The young to old transfer was estimated by averaging the consumption across the young
and old periods, and taking the difference between the smoothed and unsmoothed consumption.
Admittedly, this is only part of the benefit of the transfer—the amount applied to consumption.
The other part is the benefit gained by applying some of the transfer to increasing health. This
is the health modify joy line, which is the difference in the amount of joy actuarial consumption
would have resulted in between employer treatment levels of health and the level in the actuarial
treatment. The rich to poor transfer was calculated by taking the difference between consumption if
was increased by (transfer + mean income)/mean income. Admin was found by the same method
as the previous transfer but with the amount of the increase in profit in the employer treatment
relative to the actuarial. Prevent death is the difference in expected mean joy at the end of life
including or not including subjects who died early.
DP - We calculated for the employer subjects net payments to the insurer, summing withholdings
and premium paid less health regenerated from insurance, for each age and income combination.
The administration cost is the adjustment required for the employer plan to have the same profit
as the actuarial plan, $-0.53 per subject per period. For the administration line we reran the DP
adjusting the income each period by this amount. The young to old and low to high transfer lines
follow the same logic. After adjusting for the difference in administration costs, we found the mean
for age or income and used that amount to adjust the DP’s income. We report the difference in Joy
earned with adjusted and unadjusted income. The Joy Modified income line is not calculated for
the DP, because using method above the DP increases it income so this is already included. The
prevent death line is not calculated because there were no lives under either treatment in which
the DP died prematurely.
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